Pacira Pharmaceuticals appoints new CFO
This article was originally published in Scrip
The US acute care speciality company Pacira Pharmaceuticalshas named James Scibetta chief financial officer. Mr Scibetta has more than 20 years' experience in private and public companies, as well as in investment banking. Most recently he was a consultant to Genzyme following his role as CFO of Bioenvision, which was sold to Genzyme in 2007 for $345 million. Before Bioenvision, Mr Scibetta was executive vice-president and CFO of Merrimack Pharmaceuticals.